期刊
ARCHIVES OF INTERNAL MEDICINE
卷 168, 期 14, 页码 1568-1575出版社
AMER MEDICAL ASSOC
DOI: 10.1001/archinte.168.14.1568
关键词
-
资金
- NIA NIH HHS [U01 AG012535, U01 AG012553, U01 AG012495, AG012531, U01 AG012539, AG012495, U01 AG012546, U01 AG012531, AG012505, AG012546, U01 AG012505-12, AG012553, U01 AG012554, AG012554, AG012535, U01 AG012505, AG012539] Funding Source: Medline
- NINR NIH HHS [NR004061, U01 NR004061] Funding Source: Medline
Background: Cross-sectional studies suggest that prevalence of the metabolic syndrome (MetS) increases from premenopause to postmenopause in women, independent of age. Little is known about why. We hypothesized that the incidence of the MetS increases with progression through menopause and that this increase is explained by the progressive androgenicity of the hormonal milieu. Methods: This longitudinal, 9-year study of 949 participants in the Study of Women's Health Across the Nation investigates the natural history of the menopausal transition. Participants of 5 ethnicities at 7 geographic sites were recruited when they were premenopausal or early perimenopausal and were eligible for this study if they (1) reached menopause during the study; (2) had never taken hormone therapy, and (3) did not have diabetes mellitus or the MetS at baseline. The primary outcome was the presence of MetS using National Cholesterol Education Program Adult Treatment Panel III criteria. Secondary outcomes were the components of the MetS. Results: By the final menstrual period, 13.7% of the women had new-onset MetS. Longitudinal analyses, centered at the final menstrual period, were adjusted for age at menopause, ethnicity, study site, marital status, education, body mass index, smoking, and aging. Odds of developing the MetS per year in perimenopause were 1.45 (95% confidence interval, 135-1.56) after menopause, 1.24 (95% confidence interval, 1.18-1.30). These odds were significantly different (P < .001). An increase in bioavailable testosterone or a decrease in sex hormone-binding globulin levels increased the odds. Conclusions: As testosterone progressively dominates the hormonal milieu during the menopausal transition, the prevalence of MetS increases, independent of aging and other important covariates. This may be a pathway by which cardiovascular disease increases during menopause.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据